Pulmonology最新文献

筛选
英文 中文
Handgrip strength and respiratory disease mortality: Longitudinal analyses from SHARE 握力与呼吸系统疾病死亡率:来自 SHARE 的纵向分析。
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2022.09.007
{"title":"Handgrip strength and respiratory disease mortality: Longitudinal analyses from SHARE","authors":"","doi":"10.1016/j.pulmoe.2022.09.007","DOIUrl":"10.1016/j.pulmoe.2022.09.007","url":null,"abstract":"<div><h3>Background</h3><p>While the association between handgrip strength and all-cause mortality is more deeply explored, no previous studies have been specifically focused on handgrip strength and respiratory disease mortality. The purpose of the study was to investigate the association between handgrip strength and respiratory disease mortality in a large representative sample.</p></div><div><h3>Methods</h3><p>Individuals aged 50 or over from 27 European countries and Israel participated in this longitudinal study. Data on handgrip strength and all-cause and respiratory disease mortality were retrieved from the Survey of Health, Ageing and Retirement in Europe (SHARE) waves 1, 2, 4, 5, 6 and 7. We estimated the sub hazard ratios (SHRs) for respiratory disease mortality using a Fine-Gray sub-distribution method with both time-varying exposure and covariates and mortality due to other causes as competing risk. Furthermore, we assessed dose‐response associations of handgrip strength (modelled as a continuous exposure) with respiratory disease mortality using restricted cubic splines and estimated hazard ratios (HRs).</p></div><div><h3>Results</h3><p>We included 60,883 men and 74,904 women with a mean age of 63.6 (SD 9.7) years at study entry. During a median (interquartile range) of 7.4 years of follow-up 565 (0.4%) participants died due to respiratory diseases. The increase of 1 single kg of handgrip strength showed a 6% incidence reduction on respiratory disease mortality (SHR, 0.94; 95%CI, 0.92-0.96) after adjusting for potential confounders. Furthermore, each kg increase of handgrip strength reduced respiratory disease mortality risk in a dose-response fashion and a significant threshold for values of 41 kg (HR, 0.49; 95%CI, 0.26-0.92) and higher was identified.</p></div><div><h3>Conclusions</h3><p>Higher handgrip strength is associated with lower mortality due to respiratory disease. Intervention studies are needed to determine whether strength training in respiratory disease patients can prevent premature mortality.</p></div>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 445-451"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043722002240/pdfft?md5=043f807b498948efc45212a3c9fc302f&pid=1-s2.0-S2531043722002240-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40563917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine 老年人和慢性病患者的流感疫苗接种:葡萄牙肺脏病学会、葡萄牙糖尿病学会、葡萄牙心脏病学会、葡萄牙老年病学和老年医学学会、葡萄牙内科学会老年病学研究小组以及葡萄牙传染病和临床微生物学学会的立场文件
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.11.003
{"title":"Influenza vaccination in older adults and patients with chronic disorders: A position paper from the Portuguese Society of Pulmonology, the Portuguese Society of Cardiology, the Portuguese Society of Diabetology, the Portuguese Society of Infectious Diseases and Clinical Microbiology, the Portuguese Society of Geriatrics and Gerontology, and the Study Group of Geriatrics of the Portuguese Society of Internal Medicine","authors":"","doi":"10.1016/j.pulmoe.2023.11.003","DOIUrl":"10.1016/j.pulmoe.2023.11.003","url":null,"abstract":"<div><p>Influenza affects millions of people worldwide each year and can lead to severe complications, hospitalizations, and even death, especially among vulnerable populations such as older adults and those with chronic medical conditions. Annual vaccination is considered the most effective measure for preventing influenza and its complications. Despite the widespread availability of influenza vaccines, however, vaccination coverage rates remain suboptimal in several countries. Based on the latest scientific evidence and expert opinions on influenza vaccination in older people and patients with chronic disease, the Portuguese Society of Pulmonology (SPP), the Portuguese Society of Diabetology (SPD), the Portuguese Society of Cardiology (SPC), the Portuguese Society of Geriatrics and Gerontology (SPGG), the Study Group of Geriatrics of the Portuguese Society of Internal Medicine (NEGERMI-SPMI), and the Portuguese Society of Infectious Diseases and Clinical Microbiology (SPDIMC) discussed best practices for promoting vaccination uptake and coverage and drew up several recommendations to mitigate the impact of influenza. These recommendations focus on the efficacy and safety of available vaccines; the impact of influenza vaccination on older adults; patients with chronic medical conditions, namely cardiac and respiratory conditions, diabetes, and immunosuppressive diseases; and health care professionals, optimal vaccination timing, and strategies to increase vaccination uptake and coverage. The resulting position paper highlights the critical role that vaccinations play in promoting public health, raising awareness, and encouraging more people to get vaccinated.</p></div>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 422-436"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723002015/pdfft?md5=4f48b88e1640955d2807f32f334e0d9c&pid=1-s2.0-S2531043723002015-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138824883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of high-flow nasal cannula therapy in elderly patients with acute respiratory failure 高流量鼻插管疗法对急性呼吸衰竭老年患者的疗效和安全性。
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.01.004
{"title":"Efficacy and safety of high-flow nasal cannula therapy in elderly patients with acute respiratory failure","authors":"","doi":"10.1016/j.pulmoe.2023.01.004","DOIUrl":"10.1016/j.pulmoe.2023.01.004","url":null,"abstract":"<div><h3>Introduction</h3><p>To assess the efficacy and safety of high-flow nasal cannula (HFNC) in elderly patients with acute respiratory failure (ARF) not due to COVID-19, refractory to treatment with conventional oxygen therapy and/or intolerant to noninvasive ventilation (NIV) or continuous positive airway pressure (CPAP) and without criteria for admission to intensive care units (ICU).</p></div><div><h3>Methods</h3><p>Prospective observational study of patients with ARF treated with HFNC who presented clinical and arterial blood gas deterioration after 24 h of medical treatment and oxygenation by conventional systems. The degree of dyspnoea, gas exchange parameters (arterial O<sub>2</sub> pressure/inspired O<sub>2</sub> fraction ratio (PaO<sub>2</sub>/FiO<sub>2</sub>); oxygen saturation measured by oximetry/ inspired fraction of oxygen (Sp0<sub>2</sub>/Fi0<sub>2</sub>), ROX index), degree of patient tolerance and mortality were evaluated. These were measured at discharge from the emergency department (ED), 24 h after treatment with conventional oxygenation and 60, 120 min and 24 h after initiation of HFNC. The results were analyzed for all patients as a whole and for patients with hypercapnia (arterial carbon dioxide tension (PaCO<sub>2</sub>) &lt; 45 mmHg) separately.</p></div><div><h3>Results</h3><p>200 patients were included in the study between November 2019 and November 2020, with a mean age of 83 years, predominantly women (61.9%), obese (Body Mass Index (BMI) 31.1), with high comorbidity (Charlson index 4) and mild-moderate degree of dependence (Barthel 60). A number of 128 patients (64%) were hypercapnic. None had respiratory acidosis (pH 7.39). Evaluation at 60 min, 120 min and 24 h showed significant improvement in all patients and in the subgroup of hypercapnic patients with respect to baseline parameters in respiratory rate (RR), dyspnoea, ROX index, PaO<sub>2</sub>/FiO<sub>2</sub>, SpO<sub>2</sub>/FiO<sub>2</sub> and patient comfort. No changes in PaCO<sub>2</sub> or level of consciousness were observed. HFNC was well tolerated. Ten patients (5%) died due to progression of the disease causing ARF.</p></div><div><h3>Conclusions</h3><p>HFNC is an effective and safe alternative in elderly patients with ARF not due to COVID-19, refractory to treatment with conventional oxygen therapy and/or intolerant to NIV or CPAP and without criteria for admission to ICU.</p></div>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 437-444"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9291406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transbronchial lung cryobiopsy for peripheral pulmonary lesions. A narrative review 经支气管肺冷冻活检治疗周围肺部病变。叙述性评论。
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.08.010
{"title":"Transbronchial lung cryobiopsy for peripheral pulmonary lesions. A narrative review","authors":"","doi":"10.1016/j.pulmoe.2023.08.010","DOIUrl":"10.1016/j.pulmoe.2023.08.010","url":null,"abstract":"<div><p>An increasing number of peripheral pulmonary lesions (PPLs) requiring tissue verification to establish a definite diagnosis for further individualized management are detected due to the growing adoption of lung cancer screening by chest computed tomography (CT), especially low-dose CT. However, the morphological diagnosis of PPLs remains challenging. Transbronchial lung cryobiopsy (TBLC) that can retrieve larger specimens with more preserved cellular architecture and fewer crush artifacts in comparison with conventional transbronchial forceps biopsy (TBFB), as an emerging technology for diagnosing PPLs, has been demonstrated to have the potential to resolve the clinical dilemma pertaining to currently available sampling devices (e.g., forceps, needle and brush) and become a diagnostic cornerstone for PPLs. Of note, with the introduction of the 1.1 mm cryoprobe that will be more compatible with advanced bronchoscopic navigation techniques, such as radial endobronchial ultrasound (r-EBUS), virtual bronchoscopic navigation (VBN) and electromagnetic navigation bronchoscopy (ENB), the use of TBLC is expected to gain more popularity in the diagnosis of PPLs. While much remains for exploration using the TBLC technique for diagnosing PPLs, it can be envisaged that the emergence of additional studies with larger data accrual will hopefully add to the body of evidence in this field.</p></div>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 475-484"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723001630/pdfft?md5=6264a5249f665243010d0d1bf573bc23&pid=1-s2.0-S2531043723001630-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429162","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRALI: A differential diagnosis to keep in mind TRALI:需要牢记的鉴别诊断
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.11.010
{"title":"TRALI: A differential diagnosis to keep in mind","authors":"","doi":"10.1016/j.pulmoe.2023.11.010","DOIUrl":"10.1016/j.pulmoe.2023.11.010","url":null,"abstract":"","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 495-497"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723002362/pdfft?md5=8b43e6d73158e74f78cccd562f79b68d&pid=1-s2.0-S2531043723002362-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138818901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exuberant endobronchial sarcoidosis – An uncommon form of sarcoidosis 旺盛支气管内肉样瘤病--一种不常见的肉样瘤病
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2024.01.003
{"title":"Exuberant endobronchial sarcoidosis – An uncommon form of sarcoidosis","authors":"","doi":"10.1016/j.pulmoe.2024.01.003","DOIUrl":"10.1016/j.pulmoe.2024.01.003","url":null,"abstract":"","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 500-501"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043724000084/pdfft?md5=9f85d46c78df6ff8a002bed90f41cf07&pid=1-s2.0-S2531043724000084-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139668850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Artificial Intelligence is changing scientific publishing? Unrequested advices for young researchers II 人工智能如何改变科学出版?给年轻研究人员的不二建议 II.
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2024.04.011
Stefano Mazzoleni , Nicolino Ambrosino
{"title":"How Artificial Intelligence is changing scientific publishing? Unrequested advices for young researchers II","authors":"Stefano Mazzoleni ,&nbsp;Nicolino Ambrosino","doi":"10.1016/j.pulmoe.2024.04.011","DOIUrl":"10.1016/j.pulmoe.2024.04.011","url":null,"abstract":"","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 413-415"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043724000588/pdfft?md5=b22ca7cfe47d7beede00293de3512707&pid=1-s2.0-S2531043724000588-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of cryobiopsy and forceps biopsy for the diagnosis of mediastinal lesions: A randomised clinical trial 冷冻活检与镊子活检在纵隔病变诊断中的比较:随机临床试验
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.12.002
{"title":"Comparison of cryobiopsy and forceps biopsy for the diagnosis of mediastinal lesions: A randomised clinical trial","authors":"","doi":"10.1016/j.pulmoe.2023.12.002","DOIUrl":"10.1016/j.pulmoe.2023.12.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the standard approach for lung cancer staging. However, its diagnostic utility for other mediastinal diseases might be hampered by the limited tissue retrieved. Recent evidence suggests the novel sampling strategies of forceps biopsy and cryobiopsy as auxiliary techniques to EBUS-TBNA, considering their capacity for larger diagnostic samples.</p></div><div><h3>Methods</h3><p>This study determined the added value of forceps biopsy and cryobiopsy for the diagnosis of mediastinal diseases. Consecutive patients with mediastinal lesions of 1 cm or more in the short axis were enrolled. Following completion of needle aspiration, three forceps biopsies and one cryobiopsy were performed in a randomised pattern. Primary endpoints included diagnostic yield defined as the percentage of patients for whom mediastinal biopsy led to a definite diagnosis, and procedure-related complications.</p></div><div><h3>Results</h3><p>In total, 155 patients were recruited and randomly assigned. Supplementing EBUS-TBNA with either forceps biopsy or cryobiopsy increased diagnostic yield, with no significant difference between EBUS-TBNA plus forceps biopsy and EBUS-TBNA plus cryobiopsy (85.7 % versus 91.6 %, <em>P</em> = 0.106). Yet, samples obtained by additional cryobiopsies were more qualified for lung cancer molecular testing than those from forceps biopsies (100.0 % versus 89.5 %, <em>P</em> = 0.036). When compared directly, the overall diagnostic yield of cryobiopsy was superior to forceps biopsy (85.7 % versus 70.8 %, <em>P</em> = 0.001). Cryobiopsies produced greater samples in shorter procedural time than forceps biopsies. Two (1.3 %) cases of postprocedural pneumothorax were detected.</p></div><div><h3>Conclusions</h3><p>Transbronchial mediastinal cryobiopsy might be a promising complementary tool to supplement traditional needle biopsy for increased diagnostic yield and tissue harvesting.</p></div><div><h3>Trial registration</h3><p>ChiCTR2000030373</p></div>","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 466-474"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723002404/pdfft?md5=b2b5df9afcfa6aef2a10e8a1f17a3716&pid=1-s2.0-S2531043723002404-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139104669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcutaneous capnometry-guided exercise in respiratory settings 呼吸环境下经皮血压引导的运动
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.12.003
{"title":"Transcutaneous capnometry-guided exercise in respiratory settings","authors":"","doi":"10.1016/j.pulmoe.2023.12.003","DOIUrl":"10.1016/j.pulmoe.2023.12.003","url":null,"abstract":"","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 498-499"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723002416/pdfft?md5=6039b365ffb09bb6303b1b9ff0988517&pid=1-s2.0-S2531043723002416-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139104967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchiectasis as long-term complication of acute fire smoke inhalation? 支气管扩张是急性火灾烟雾吸入的长期并发症吗?
IF 10.4 2区 医学
Pulmonology Pub Date : 2024-09-01 DOI: 10.1016/j.pulmoe.2023.09.001
{"title":"Bronchiectasis as long-term complication of acute fire smoke inhalation?","authors":"","doi":"10.1016/j.pulmoe.2023.09.001","DOIUrl":"10.1016/j.pulmoe.2023.09.001","url":null,"abstract":"","PeriodicalId":54237,"journal":{"name":"Pulmonology","volume":"30 5","pages":"Pages 492-494"},"PeriodicalIF":10.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2531043723001642/pdfft?md5=a18a13d8dfb5ba3ca82150399d972616&pid=1-s2.0-S2531043723001642-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41147010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信